Delivery Order SPE2DR25D3201-SPE2DR26FT4HL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,505.73 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30 on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed price, competitively awarded delivery order represents a direct procurement of pharmaceutical products to support federal medical supply needs. The contract is non-set-aside and will be performed from AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a competitive delivery order valued at $11,825.31 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with an ultimate completion date of October 21, 2025. This non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement, with performance of work occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.29 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,038.76 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with a firm fixed price arrangement. This non-competitive delivery order is scheduled for completion by December 12, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,215.65 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Arimidex 1 mg tablets (30 count). The award is non-competitive and issued under a firm fixed-price delivery order contract type, with an ultimate completion date of November 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4HLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $44,901.48 to AmerisourceBergen Drug Corp for the supply of Arimidex (anastrozole) 1 mg tablets in quantities of 30, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contract awards demonstrates its capacity to meet procurement requirements for specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains through open competition. This delivery order exemplifies the company's ongoing role as a primary pharmaceutical supplier for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.9k | 11/25/25 |